Company Opyl Limited Australian S.E.
Equities
OPL
AU0000062838
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% | -.--% | -.--% |
04-29 | Opyl Expands TrialKey Coverage; Shares Up 38% | MT |
04-23 | Opyl to Divest Opin Business | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Project
57.3
%
| 1 | 69.5 % | 0 | 57.3 % | -43.56% |
Retainer
42.0
%
| 0 | 28.1 % | 0 | 42.0 % | +2.42% |
Other
0.7
%
| 0 | 2.4 % | 0 | 0.7 % | -80.14% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -31.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Jain
CEO | Chief Executive Officer | - | 11-23 |
Marc Angelone
FOU | Founder | - | 16/01/94 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 29/01/19 |
Shane Lewis
SAM | Sales & Marketing | - | - |
David Lilja
SEC | Corporate Secretary | - | 09/12/19 |
Jason D. Weaver
PRN | Corporate Officer/Principal | - | 16/07/17 |
Scott Sorochak
PRN | Corporate Officer/Principal | - | 29/05/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
BRD | Director/Board Member | 54 | 03/09/23 |
Antanas Guoga
BRD | Director/Board Member | 50 | 03/09/23 |
Marc Angelone
FOU | Founder | - | 16/01/94 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 29/01/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 124,527,257 | 84,437,463 ( 67.81 %) | 0 | 67.81 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+5.85% | 32.93B | |
+20.16% | 7.94B | |
+30.81% | 4.19B | |
-25.95% | 2.8B | |
-19.96% | 1.38B | |
-31.87% | 1.17B | |
+8.02% | 966M | |
-35.73% | 900M | |
-25.74% | 839M |
- Stock Market
- Equities
- OPL Stock
- OPL Stock
- Company Opyl Limited